Introduction {#sec1-1759091418801092}
============

Fragile X syndrome (FXS) is the most prevalent cause of inherited intellectual disability and is a leading genetic cause of autism ([@bibr40-1759091418801092]). FXS affects 1 in 4,000 boys and 1 in 8,000 girls and is caused by the silencing, deletion, or loss-of-function mutation of the *fragile X mental retardation 1* (*FMR1*) *gene*. As a result, its protein product, fragile X mental retardation protein (FMRP), is either not expressed or is nonfunctional ([@bibr211-1759091418801092]; [@bibr198-1759091418801092]; [@bibr153-1759091418801092]). FMRP is a messenger RNA (mRNA)-binding protein ([@bibr9-1759091418801092]) that regulates several aspects of mRNA metabolism such as nuclear export, transport to synaptic terminals, activity-dependent ribosome stalling, and protein translation ([@bibr128-1759091418801092]; [@bibr11-1759091418801092]; [@bibr19-1759091418801092]; [@bibr47-1759091418801092]; [@bibr176-1759091418801092]).

FMRP regulates translation of mRNAs at synapses, some of which encode proteins involved in synaptic plasticity ([@bibr29-1759091418801092]; [@bibr222-1759091418801092]). The absence of FMRP leads to the dysregulation of protein translation and increased protein synthesis ([@bibr20-1759091418801092]; [@bibr46-1759091418801092]), which may contribute to altered metabotropic glutamate receptor 5 (mGluR5) signaling resulting in exaggerated long-term depression (LTD) in the hippocampus ([@bibr111-1759091418801092]). FMRP also negatively regulates matrix metalloproteinase-9 (MMP-9) translation in neurons ([@bibr64-1759091418801092]; [@bibr119-1759091418801092]; [@bibr63-1759091418801092]), and MMP-9 levels are elevated in FXS ([@bibr24-1759091418801092]; Gkogkas et al., [@bibr92-1759091418801092]; [@bibr187-1759091418801092]). mGluR5 and MMP-9 may mediate changes in synaptic functions by signaling through the phosphatidylinositide-3-kinase (PI3K)/mammalian target of rapamycin complex 1 (mTORC1) and extracellular signal-regulated kinase pathways to increase cap-dependent translation ([@bibr80-1759091418801092]; [@bibr86-1759091418801092]; [@bibr109-1759091418801092]; [@bibr125-1759091418801092]; [@bibr14-1759091418801092]; [@bibr108-1759091418801092]; [@bibr6-1759091418801092]; [@bibr169-1759091418801092]; [@bibr184-1759091418801092]). Recent data suggest that FMRP may also directly regulate PI3K and mTORC1 signaling through other signaling proteins, such as phosphatidylinositide-3-kinase enhancer, phosphatase and tensin homolog, neurofibromin 1, and tuberous sclerosis 2 ([@bibr184-1759091418801092]; [@bibr71-1759091418801092]; [@bibr178-1759091418801092]). In addition, all three isoforms of eukaryotic translation initiation factor 4 G, eukaryotic translation elongation factor 1 and 2, argonaute proteins, and Dicer are FMRP targets, and their dysregulation may also contribute to enhanced neuronal translation in FXS ([Figure 1](#fig1-1759091418801092){ref-type="fig"}; [@bibr33-1759091418801092]; [@bibr47-1759091418801092]; [@bibr143-1759091418801092]).

![Mechanisms of sensory phenotypes associated with FXS. Fragile X syndrome is associated with an expansion of CGG repeats in 5′ untranslated area of the fragile X mental retardation 1 (*Fmr1*) gene, which leads to silencing *Fmr1* gene and a partial or full loss of the fragile X mental retardation protein (FMRP). FMRP is an RNA-binding protein that regulates translation of mRNAs at synapses, some of which encode proteins involved in protein synthesis and synaptic plasticity. FMRP is known to regulate protein translation through eukaryotic translation elongation factor 1/2 (eEF1/2), argonaute proteins (Ago1/2), eukaryotic translation initiation factor 4 E/G (eIF4E/G), and Dicer. FMRP may also directly regulate phosphatidylinositide-3-kinase (PI3K), Akt, mammalian target of rapamycin (mTOR), and extracellular signal-regulated kinase (ERK) signaling. Lack of FMRP also leads to enhanced metabotropic glutamate receptor 5 (mGluR5)-mediated long-term depression (LTD), reduced voltage and Ca^2+^ activated K^+^ (BK) channel activity, and increased matrix metalloproteinase-9 (MMP-9) activity, which affect cellular responses resulting in reduced inhibition, impaired development of parvalbumin (PV) interneurons and perineuronal nets (PNN), increased UP states, and abnormal dendritic spine development. These molecular and cellular alterations can contribute to system-level changes, such as impaired development of neural circuits, enhanced resting gamma, and altered excitatory/inhibitory (E/I) balance, which may underlie sensory hypersensitivity and altered behaviors observed in FXS.](10.1177_1759091418801092-fig1){#fig1-1759091418801092}

Dysregulated PI3K/mTOR signaling, enhanced mGluR5-dependent LTD, increased MMP-9 activity, and reduced activity of the voltage and Ca^2+^ activated K^+^ (BKCa or BK) channel may contribute to the immature dendritic spine morphology in rodent models of FXS ([Figure 1](#fig1-1759091418801092){ref-type="fig"}; [@bibr112-1759091418801092]; [@bibr151-1759091418801092]; [@bibr207-1759091418801092]; [@bibr109-1759091418801092]; [@bibr110-1759091418801092]; [@bibr187-1759091418801092]). In mice, FMRP may also regulate neuronal branching ([@bibr87-1759091418801092]) as well as dendritic spine development ([@bibr151-1759091418801092]). Consistent with animal work, clinical studies revealed alterations in dendritic spine number and morphology in the cortex of FXS humans, with a prevalence of immature dendritic spines ([@bibr107-1759091418801092]; [@bibr114-1759091418801092]). In fact, dendritic abnormalities are consistent anatomical correlates of intellectual disability ([@bibr122-1759091418801092]). Although most of FMRP activity is considered to be related to the regulation of synaptic functions ([@bibr228-1759091418801092]; [@bibr66-1759091418801092]; [@bibr47-1759091418801092]), little is known about how the synaptic alterations in the absence of FMRP may lead to deficits in neurophysiology and behavior in humans with FXS. Abnormal dendritic spine development alone cannot explain increased cortical excitability observed in FXS.

FMRP loss increases network-level hyperexcitability in the rodent cortex through impaired inhibition and altered neural synchrony ([Figure 1](#fig1-1759091418801092){ref-type="fig"}; [@bibr93-1759091418801092]; [@bibr226-1759091418801092]). The *Fmr1* KO mouse shows decreased gamma-aminobutyric acid (GABA) receptor levels, decreased GABA synthesis, increased GABA catabolism, and overall decreased GABAergic input in many regions of the brain ([@bibr69-1759091418801092]; [@bibr54-1759091418801092]; [@bibr183-1759091418801092]; [@bibr42-1759091418801092]; [@bibr55-1759091418801092]; [@bibr2-1759091418801092]; [@bibr135-1759091418801092]). FMRP was also shown to regulate neuronal excitability through the direct interactions with several ion channels, such as sodium‐activated potassium channel Slack, presynaptic N‐type voltage‐gated calcium channels, and calcium‐activated potassium BK channels ([@bibr28-1759091418801092]; [@bibr227-1759091418801092]; [@bibr52-1759091418801092]; [@bibr81-1759091418801092]; [@bibr103-1759091418801092]; [@bibr147-1759091418801092]). The enhanced excitability is associated with neurological symptoms observed in FXS, such as hypersensitivity, hyperarousal, hyperactivity, anxiety, and seizures ([Figure 1](#fig1-1759091418801092){ref-type="fig"}; [@bibr161-1759091418801092]; [@bibr26-1759091418801092]). However, limited knowledge of the neuronal circuits underlying complex behaviors, such as anxiety and communication deficits, has hindered the progress in translating the results of the mouse studies into successful clinical trials. Potential mechanisms of altered neuronal circuit excitability and how these changes might impact sensory perception and behavior in FXS are beginning to be understood. In this review, we bring together clinical, functional, and neuroanatomical studies that outline auditory, visual, and somatosensory processing deficits in FXS and how understanding these mechanisms using preclinical studies in animal models can help our search for new therapeutic applications in FXS.

Animal Models of FXS {#sec2-1759091418801092}
====================

To understand the molecular and cellular pathogenesis of FXS, the disease has been successfully modeled in rodents ([@bibr12-1759091418801092]; [@bibr65-1759091418801092]; [@bibr96-1759091418801092]), *Drosophila* ([@bibr158-1759091418801092]), and zebrafish ([@bibr50-1759091418801092]). The mouse *Fmr1* gene product shows 97% homology to human FMRP ([@bibr8-1759091418801092]). The *Fmr1* knockout (KO) mouse model was generated with phenotypes similar to those observed in human FXS patients, such as progressive macroorchidism ([@bibr12-1759091418801092]) and abnormal dendritic spine development ([@bibr151-1759091418801092]). *Fmr1* KO mice also demonstrate impaired cognitive functions and aberrant behaviors ([@bibr219-1759091418801092]; [@bibr100-1759091418801092]). More robust cognitive deficits have been identified in studies of memory extinction that include inhibitory avoidance paradigm, trace fear conditioning, and lever-press escape/avoidance tasks ([@bibr230-1759091418801092]; [@bibr27-1759091418801092]; [@bibr60-1759091418801092]; [@bibr100-1759091418801092]; [@bibr65-1759091418801092]). Susceptibility to age-dependent audiogenic seizures is another reproducible phenotype observed in *Fmr1* KO mice ([@bibr34-1759091418801092]; [@bibr219-1759091418801092]; [@bibr60-1759091418801092]). The mouse FXS model is also tractable for electrophysiology experiments to define the synaptic alterations associated with FXS. *Fmr1* KO hippocampal neurons show enhanced metabotropic glutamate receptor (mGluR5)-dependent LTD ([@bibr111-1759091418801092]). Other studies have shown deficits in long-term potentiation (LTP) in the hippocampus, cortex, and the lateral amygdala ([@bibr134-1759091418801092]; [@bibr130-1759091418801092]; [@bibr230-1759091418801092]; [@bibr53-1759091418801092]; [@bibr212-1759091418801092]; [@bibr217-1759091418801092]), suggesting alterations in synaptic plasticity that may underlie deficits in experience-dependent brain functions in FXS.

The development of the *Fmr1* KO rat model allows for modeling more complex cognitive and social behaviors associated with FXS ([@bibr96-1759091418801092]). It also provides an opportunity for comparison of phenotypes across mammalian species that result from FMRP deletion. Similar to mouse studies, mGluR-LTD was enhanced in *Fmr1* KO rats, whereas mGluR LTP was significantly decreased at both cortical and thalamic inputs to the lateral amygdala ([@bibr116-1759091418801092]). Adult *Fmr1* KO rats also showed disrupted cortical processing of auditory stimuli ([@bibr70-1759091418801092]), recapitulated spine density and synaptic plasticity defects observed in mouse models, and displayed deficits in hippocampal forms of associative recognition memory ([@bibr201-1759091418801092]) and novel social interaction phenotypes ([@bibr96-1759091418801092]). Juvenile *Fmr1* KO rats exhibit abnormal cortical state regulation that begins at ages equivalent to human birth ([@bibr23-1759091418801092]). Despite largely normal patterns of spontaneous activity during the first two postnatal weeks before eye opening, *Fmr1* KO rats exhibit signs of mild hyperexcitability during the third and fourth postnatal weeks, including an increase in the visually evoked firing of excitatory neurons and reduced firing of inhibitory neurons ([@bibr23-1759091418801092]).

Similar to the rodent models of FXS, the fruit fly (*Drosophila*) is a powerful genetic model organism for study of FXS. The single FMRP homolog, dFMRP, is well conserved to human FMRP with respect to its functional amino acid motifs ([@bibr213-1759091418801092]) and RNA-binding properties ([@bibr45-1759091418801092]). The fly FXS model system has collectively yielded much insight into the cognitive, behavioral, and morphological phenotypes associated with FXS. Morphological analyses of fly neurons have identified defects in axons and dendrites of specific neuronal subsets, in particular in the neuromuscular junction and the mushroom body. In the absence of *dFmr1* activity, the axons within the neuromuscular junction display significant increase in synaptic boutons and branching ([@bibr228-1759091418801092]). Neurons in the mushroom body, a brain area that is required for short-term and long-term memory, are also affected in *dFmr1* mutants ([@bibr139-1759091418801092]; [@bibr224-1759091418801092]; [@bibr160-1759091418801092]). Moreover, long-term memory defects have been reported in *dFmr1* mutants using olfactory-based assays ([@bibr25-1759091418801092]). dFMRP has also been shown to be necessary for long-term, but not short-term olfactory habituation, as indicated by an olfactory avoidance task ([@bibr196-1759091418801092]). Electrophysiology analysis also shows defects in synaptic transmission in the optic lobe ([@bibr228-1759091418801092]). In addition to axonal, dendritic, and synaptic transmission defects, male *dFmr1*-null flies also have enlarged testes, a phenotype that is observed in both FXS humans and *Fmr1* KO mice ([@bibr229-1759091418801092]). Similar to *Fmr1* KO mice ([@bibr225-1759091418801092]), *dFmr1*-null flies lack the ability to maintain a normal circadian rhythm when placed in total darkness and exhibit erratic patterns of locomotor activity ([@bibr58-1759091418801092]; [@bibr113-1759091418801092]; [@bibr142-1759091418801092]; [@bibr218-1759091418801092]). They also lack interest in courtship ([@bibr58-1759091418801092]), a social impairment similar to that found in autism. Furthermore, FXS flies exhibit impaired olfactory behaviors. The absence of dFMRP results in reduced olfactory attraction and aversion. Calcium imaging data show that antennal lobe projection neurons have broader odor tuning in *dFmr1* flies, leading to reduced specificity in odor coding and alterations in olfactory representations. Consistent with these results, lateral inhibition across olfactory glomeruli, as well as the inhibitory connections between local interneurons and projection neurons are impaired in *dFmr1* flies ([@bibr83-1759091418801092]). This suggests that absence of dFMRP leads to abnormal lateral inhibition across olfactory glomeruli, which, in turn, results in impaired odor coding and olfactory behaviors. Thus, the fly FXS model displays significant social, cognitive, and sensory deficits that can be used to examine the underlying mechanisms.

Zebrafish is a more recent animal model that has shown potential as a complementary vertebrate model in studying the pathophysiology of FXS. The adult zebrafish FMRP shares 72% amino acid identity with human FMRP and is highly expressed in the brain, including in the telencephalon, diencephalon, metencephalon, and cerebellum, and spinal cord ([@bibr210-1759091418801092]). In adult zebrafish, *Fmr1* KO produces the anxiolytic-like responses of increased exploratory behavior in light/dark and open-field tests and avoidance learning impairment, indicating that hyperactivity and anxiety can be also tested in *Fmr1* KO zebrafish. Furthermore, electrophysiological recordings from telencephalic slice preparations of *Fmr1* KO zebrafish displayed markedly reduced LTP and enhanced LTD compared to wild-type (WT) counterparts ([@bibr148-1759091418801092]). Animal models of FXS have a great potential for elucidating mechanisms underlying cognitive, behavioral, and morphological phenotypes associated with FXS, as well as preclinical studies.

Auditory Hypersensitivity and Underlying Mechanisms {#sec3-1759091418801092}
===================================================

Auditory hypersensitivity is common in humans with FXS and mouse models of FXS ([@bibr174-1759091418801092]; [@bibr192-1759091418801092]). Notably, studies indicate abnormalities in auditory processing in people with FXS ([@bibr194-1759091418801092]; [@bibr168-1759091418801092]; [@bibr32-1759091418801092]; [@bibr208-1759091418801092]; [@bibr182-1759091418801092]). Tone-evoked responses measured using magnetic fields are higher in the auditory cortex of humans with FXS ([@bibr168-1759091418801092]). Increased activation of left hemispheric circuitry, including superior temporal gyrus, was observed in FXS subjects during auditory temporal discrimination task ([@bibr95-1759091418801092]). To assess sensory-cognitive processing in humans with FXS, various event-related brain potential (ERP) techniques have been employed. ERPs reflect the activity of neuronal populations in response to specific sensory-cognitive processes and can be detected using electroencephalograms (EEG) and magnetoencephalograms (MEG; [@bibr138-1759091418801092]). A relatively simple auditory stimulus can elicit a N1 wave in the auditory cortex. Auditory ERP studies report abnormally high amplitude of the N1 wave in response to tones and reduced habituation to repeated sound in FXS ([@bibr168-1759091418801092]; [@bibr32-1759091418801092]; [@bibr208-1759091418801092]; [@bibr182-1759091418801092]; [@bibr73-1759091418801092]). FXS patients also exhibit increased gamma frequency band power during resting state. This increased gamma activity is believed to be linked to increased neural excitability, and examining the relationship of alpha and theta band activity with gamma band activity might provide system-level understanding about the altered balance between excitatory and inhibitory activity ([@bibr214-1759091418801092]). Furthermore, a recent study shows that humans with FXS demonstrate a marked reduction in the ability to synchronize evoked high-frequency neural activity to time-varying signals, suggesting impairments in underlying neural generators involved in sensory processing ([@bibr74-1759091418801092]). These data indicate a *noisy resting state* of sensory cortex in people with FXS that may lead to abnormal synchronization of evoked responses. Auditory cortex processing abnormalities that arise early in development may contribute to higher order auditory functional deficits such as language deficits seen in FXS and autism ([@bibr166-1759091418801092]; [@bibr150-1759091418801092]; [@bibr17-1759091418801092]; [@bibr82-1759091418801092]; [@bibr167-1759091418801092]). However, very little is known about development of EEG/MEG abnormalities and correlations with language development in humans.

*Fmr1* KO mice also exhibit abnormal prepulse inhibition and auditory startle responses, with greater startle responses than WT mice to low-intensity (80 dB) white noise bursts and decreased responses to high-intensity (120 dB) white noise bursts ([@bibr149-1759091418801092]). *Fmr1* KO mice are also acoustically hypersensitive and are prone to audiogenic seizures ([@bibr140-1759091418801092]; [@bibr34-1759091418801092]; [@bibr149-1759091418801092]; [@bibr84-1759091418801092]), suggesting enhanced excitability in the auditory system. Intense auditory stimuli (\>100 dB SPL) induces a period of wild running, clonic--tonic seizing, and can result in the death of the animal ([@bibr145-1759091418801092]; [@bibr34-1759091418801092]; [@bibr146-1759091418801092]; [@bibr44-1759091418801092]). Reintroduction of FMRP to *Fmr1* KO mice significantly reduces audiogenic seizure susceptibility ([@bibr146-1759091418801092]). In addition, the audiogenic seizure phenotype of *Fmr1* KO mice is prevented by the systemic administration of the mGluR5 receptor antagonist, MPEP ([@bibr219-1759091418801092]). Enhanced susceptibility to audiogenic seizures is a robust phenomenon in *Fmr1* KO mice and is one of the most widely used outcome measures in preclinical drug discovery studies. The auditory brainstem expresses high FMRP levels ([@bibr215-1759091418801092]), and abnormal sensory processing at the level of the auditory brainstem may underlie the enhanced susceptibility to audiogenic seizures. FMRP interactions with sodium‐activated potassium channel Slack in the auditory brainstem and its ability to regulate Slack activity may also explain increased excitability in the auditory brainstem of *Fmr1* KO mice ([@bibr28-1759091418801092]). In addition, *Fmr1* KO mice show enhanced acoustic startle responses ([@bibr34-1759091418801092]; [@bibr149-1759091418801092]; [@bibr84-1759091418801092]; [@bibr221-1759091418801092]). Abnormal habituation of acoustic startle responses, which is accompanied with hypersensitivity or hyposensitivity to sensory stimuli, was also shown to be dependent on BK channel functions ([@bibr223-1759091418801092]). BK channels can directly interact with FMRP, and their functions are affected by the loss of FMRP ([@bibr52-1759091418801092]), whereas the upregulation of BK channel activity in a mouse model of FXS was shown to normalize the enhanced glutamate release and excessive epileptiform activity ([@bibr51-1759091418801092]). However, the mechanisms by which the absence of FMRP in the specific brain areas, such as brainstem or cortex, leads to the enhanced excitability need to be further studied to better understand the epileptic phenotype of FXS.

*In vivo* recordings from the auditory cortex show that the abnormal cortical processing may underlie auditory hypersensitivity in *Fmr1* KO mouse ([@bibr171-1759091418801092]). First, single-unit recordings show that cortical neurons respond to tones with more action potentials in *Fmr1* KO mice than WT neurons in both adults ([@bibr171-1759091418801092]) and P21 mice ([@bibr216-1759091418801092]). The increased responses are due to prolonged firing of action potentials well after stimulus offset. Second, there is also increased variability of spike timing, broader frequency receptive fields, and reduced spectrotemporal selectivity in the *Fmr1* KO cortex. The broader receptive fields mean that more neurons will be activated synchronously for any given sound in the KO cortex. Third, recordings from KO mice cortex to repeated sound presentation shows reduced habituation of response amplitudes. Together these findings suggest that hypersensitivity arises due to a *triple hit*---increased response per neuron, more number of responsive neurons, and reduced habituation of responses.

Remarkably similar EEG phenotypes are also present in *Fmr1* KO mice and humans with FXS ([@bibr191-1759091418801092]; [@bibr136-1759091418801092]). Lovelace et al. recorded EEG signals from both auditory and frontal cortex of awake, freely moving mice and compared the WT and *Fmr1* KO genotypes. They identified increased gamma power in baseline EEG, reduced evoked phase synchronization to auditory stimuli in the gamma band, and larger ERP N1 component amplitudes in the KO mice ([@bibr136-1759091418801092]). These data are essentially identical to findings in humans with FXS ([@bibr74-1759091418801092]; [@bibr214-1759091418801092]). Together these data support the notion that there is a milieu of noisy resting state in the auditory cortex in FXS in addition to the triple hit mentioned earlier giving rise to auditory hypersensitivity.

Most studies on humans with FXS have focused on older children or adolescents. However, abnormalities in auditory processing may arise from altered critical period plasticity during development. In the auditory cortex, *Fmr1* KO mice show abnormal critical period plasticity in response to developmental tone exposure ([@bibr124-1759091418801092]), which effectively reduces activity- or experience-evoked responses of neuronal networks. The impaired sound exposure-induced cortical map plasticity in the *Fmr1* KO mice may extend into adulthood affecting stability of auditory circuits and may underlie the abnormalities found in the adult auditory cortical responses ([@bibr171-1759091418801092]). We have proposed a specific mechanism for development of auditory hypersensitivity in the *Fmr1* KO mice ([@bibr216-1759091418801092]). Impaired development of parvalbumin (PV)-expressing inhibitory interneurons may underlie abnormal auditory processing in *Fmr1* KO mice via MMP-9-dependent regulation of perineuronal nets ([@bibr216-1759091418801092]). In normal brain, the development of PV interneurons is implicated in shaping critical period plasticity, stabilization of synaptic networks, and network synchronization ([@bibr104-1759091418801092]; [@bibr120-1759091418801092]), whereas perineuronal net loss around PV cells is associated with abnormal critical period plasticity and reduced excitability of PV cells ([@bibr162-1759091418801092]; [@bibr13-1759091418801092]; [@bibr133-1759091418801092]). The formation of perineuronal nets, which consists of extracellular matrix proteins, coincides with the closure of critical period plasticity window creating a nonpermissive environment for new synapse growth and structural plasticity. A disruption of extracellular matrix affects the stability of existing circuits and opens critical period plasticity window, which may underlie auditory hyperexcitability in FXS ([@bibr98-1759091418801092]). Studies have reported higher MMP-9 activity in *Fmr1* KO mouse brains and humans with FXS, suggesting that MMP-9 dysregulation may contribute to FXS-associated deficits ([@bibr24-1759091418801092]; [@bibr92-1759091418801092]; [@bibr187-1759091418801092]). The increased MMP-9 activity may delay the maturation of cortical circuits and extend critical period plasticity past the normal developmental window affecting the maturation of functional circuits.

The role of MMP-9 upregulation in FXS symptoms is supported by the fact that the genetic reduction of MMP-9 activity in the brain of *Fmr1* KO mice restored auditory responses and the formation of perineuronal nets around PV cells in the *Fmr1* KO mice to WT levels ([@bibr216-1759091418801092]). MMP-9 deletion in the *Fmr1* KO mice also reversed ERP N1 amplitude habituation deficits ([@bibr137-1759091418801092]). As genetic deletion of MMP-9 can also reverse FXS-associated behaviors in *Fmr1* KO mice ([@bibr24-1759091418801092]; [@bibr187-1759091418801092]), MMP-9 is an attractive therapeutic target to reduce sensory deficits in FXS and potentially other FXS-associated behaviors. Indeed, minocycline, which beside its antibiotic effects inhibits MMP-9, has emerged as a potential treatment for FXS ([@bibr24-1759091418801092]; [@bibr159-1759091418801092]; [@bibr44-1759091418801092]; [@bibr63-1759091418801092]; [@bibr132-1759091418801092]; [@bibr182-1759091418801092]; [@bibr174-1759091418801092]; [@bibr220-1759091418801092]). In humans with FXS, minocycline can reduce MMP-9 levels, reverse auditory ERP deficits, and improve FXS-associated behaviors ([@bibr159-1759091418801092]; [@bibr63-1759091418801092]; [@bibr132-1759091418801092]; [@bibr182-1759091418801092]). However, several adverse effects of minocycline, such as stained teeth, skin pigmentation, gastrointestinal disturbance, drug-induced lupus, and autoimmune hepatitis, are associated with its antibiotic properties, limiting its chronic use in humans ([@bibr67-1759091418801092]; [@bibr3-1759091418801092]; [@bibr68-1759091418801092]; [@bibr200-1759091418801092]; [@bibr203-1759091418801092]; [@bibr181-1759091418801092]; [@bibr131-1759091418801092]; [@bibr5-1759091418801092]; [@bibr185-1759091418801092]; [@bibr186-1759091418801092]; [@bibr1-1759091418801092]; [@bibr163-1759091418801092]; [@bibr30-1759091418801092]; [@bibr175-1759091418801092]; [@bibr129-1759091418801092]; [@bibr193-1759091418801092]). Therefore, there is an unmet need in developing novel, potent, and selective MMP-9 inhibitors to treat auditory hypersensitivity associated with FXS and potentially other neurodevelopmental disorders associated with sensory hypersensitivity, such as autism.

Taken together, studies of auditory processing and sensitivity in humans with FXS and *Fmr1* KO mice show remarkable overlap in phenotypes, providing a translation relevant framework for both mechanism and drug discovery. It must be noted that FMRP is expressed in multiple nuclei of the auditory system ([@bibr231-1759091418801092]), and cortical processing deficits may be intrinsic to cortical changes or inherited from subcortical sites ([@bibr195-1759091418801092]; [@bibr173-1759091418801092]; [@bibr90-1759091418801092]; [@bibr172-1759091418801092]). How multiple regions of the auditory system contribute to symptoms that range from hypersensitivity to language and communication deficits is not understood and is an important direction for future studies. The availability of mouse models in which the protein can be removed from specific neuron types, regions, and time points will aid such future studies.

Visual-Motor Deficits {#sec4-1759091418801092}
=====================

A prominent feature of the FXS neurobehavioral phenotype is diminished performance on neuropsychological tasks that assess visual‐motor function. Visuomotor dysfunction have been described for tasks that require drawing skills ([@bibr41-1759091418801092]; [@bibr85-1759091418801092]), tasks that involve manipulation of blocks to construct abstract designs ([@bibr41-1759091418801092]; [@bibr38-1759091418801092]), and tasks requiring psychomotor coordination ([@bibr38-1759091418801092]). Although these tasks are multifactorial in nature and the performance affected by many causes, visual‐motor ability is a common feature. This led to the hypothesis that the visual‐motor deficiencies observed in FXS may reflect underlying neuroanatomical and functional abnormalities specific to the thalamic component of one of the two main parallel visual pathways called the magnocellular pathway ([@bibr127-1759091418801092]). Dysfunctions of the pathway may lead to impaired visually guided actions requiring the manipulation of objects, further explaining why individuals with FXS perform poorly on a variety of neuropsychological tasks that have a visual‐motor component.

Additional behavioral studies in infants and toddlers with FXS have documented impairments in processing texture-defined motion stimuli ([@bibr77-1759091418801092]), temporal flicker ([@bibr76-1759091418801092]), perceiving the ordinality of sequences of numerical displays ([@bibr154-1759091418801092]), and the ability to maintain the identity of dynamic object information during occlusion ([@bibr75-1759091418801092]). Impaired performance has also been demonstrated on tasks requiring inhibitory control ([@bibr179-1759091418801092]) as well as numerical reasoning ([@bibr165-1759091418801092]; [@bibr144-1759091418801092]). One possible reason behind the visual-spatial and numerical deficits seen in FXS is disruption of the so-called dorsal stream (occipitoparietal visual pathway, projecting to the posterior-lateral parietal cortex, which processes information involved in guiding actions, including spatial location and motion) with relative sparing of the ventral stream (occipitotemporal visual pathway, projecting to the inferior temporal cortex, which processes object features such as form and color; [@bibr205-1759091418801092]; [@bibr141-1759091418801092]). Because of its relatively prolonged time course of development ([@bibr10-1759091418801092]), the dorsal stream is thought to be particularly vulnerable to atypical development in a number of disorders, including FXS ([@bibr126-1759091418801092]; [@bibr75-1759091418801092]).

Vision integration is affected in humans with FXS with alteration of spatiotemporal visual processing, reduction of contrast sensitivity for visual stimuli presented at high temporal frequencies, and visual sensitivity for both static and moving images ([@bibr127-1759091418801092]; [@bibr76-1759091418801092]). These deficits may be associated with a delayed development in the primary visual cortex as seen in the model of FXS premutation ([@bibr22-1759091418801092]). However, before being integrated at the cortex level, the visual signals are detected, processed, and transmitted by the retina. *Fmr1* deficiency has been shown to affect retinal function, with abnormal wiring of neuronal connections and synaptic destabilization in the retina leading to similar cellular and functional phenotypes as seen in the brain ([@bibr170-1759091418801092]). Since animal behaviors rely on sensory processing (which allows mice to integrate environmental stimuli and to adapt their action); this makes one wonder how far retinal defects, as opposed to cortical processing defects, are involved in the recorded behavioral impairments seen in *Fmr1* KO mice, such as visuospatial deficits, diminished performance on neuropsychological tasks that assess visuomotor function, and impairments in processing texture-defined motion stimuli.

Enhanced mGluR5 signaling may contribute to sensory impairments seen in *Fmr1* KO mice as mGluR5 signaling is downregulated during normal maturation and synaptic stabilization in the postnatal brain ([@bibr62-1759091418801092]). Indeed, using genetic approach, [@bibr60-1759091418801092] have shown the importance of mGluR5, as well as FMRP, in the regulation of ocular dominance plasticity during the development of visual cortex. A 50% reduction in mGluR5 expression prevents ocular dominance plasticity induced by a 3-day monocular deprivation, suggesting that this receptor normally serves to enable plasticity in the visual cortex. In contrast, in the absence of FMRP, *Fmr1* KO mice show altered ocular dominance plasticity ([@bibr60-1759091418801092]). The response to monocular deprivation is characterized by both deprived-eye response depression and open-eye response potentiation, suggesting that FMRP normally serves to restrict plasticity in the visual cortex ([@bibr59-1759091418801092]). Interestingly, since ocular dominance plasticity is protein synthesis dependent ([@bibr199-1759091418801092]), it is a possibility that excessive protein synthesis is responsible for altered plasticity in the visual cortex of *Fmr1* KO mice.

Last, by examining the visual cortices in *Fmr1* KO mice as well as those in the individuals with FXS, multiple studies have shown that FMRP is critical to the pruning and maturation of dendritic spines ([@bibr94-1759091418801092]; [@bibr114-1759091418801092]; [@bibr36-1759091418801092]). Neurons lacking FMRP retain characteristically immature dendritic spines within the visual cortex ([@bibr127-1759091418801092]). Furthermore, the density of immature spines is elevated in FXS humans compared with normal control brains. Interestingly, this immature spine phenotype is also induced by the activation of Gp1 mGluRs in the visual cortical pyramidal neurons ([@bibr207-1759091418801092]). Spine density is significantly increased in *Fmr1* KO mice, and the phenotype can be rescued by 50% reduction in mGluR5 expression ([@bibr60-1759091418801092]). This indicates that the absence of FMRP and the upregulation of mGluR5 may therefore lead to abnormal development of visual circuits and potentially impaired processing of visual stimuli.

Somatosensory Processing Deficits and Tactile Defensiveness {#sec5-1759091418801092}
===========================================================

Impaired processing of tactile information is seen in individuals with FXS, with hypersensitivity to touch being common ([@bibr31-1759091418801092]). The *Fmr1* KO mouse model has phenotypes similar to those observed in humans with FXS ([@bibr206-1759091418801092]). In mice, tactile information received through deflections of whiskers is processed in the somatosensory barrel cortex ([@bibr57-1759091418801092]; [@bibr56-1759091418801092]; [@bibr79-1759091418801092]). Correct processing of whisker-mediated touch information requires the formation of receptive fields in the somatosensory cortex ([@bibr189-1759091418801092]; [@bibr190-1759091418801092]). Development of intracortical connections plays a key role in the formation of the receptive fields and depends on sensory experience ([@bibr4-1759091418801092]; [@bibr21-1759091418801092]). Exposure of juvenile animals to patterned sensory input refined the balance of excitation and inhibition ([@bibr61-1759091418801092]; [@bibr197-1759091418801092]), resulting in receptive field and sensory map reorganization and a long-lasting impact on sound perception ([@bibr97-1759091418801092]). Therefore, the enlarged receptive fields in *Fmr1* KO mice may be a consequence of altered sensory integration during the early postnatal development.

*In vivo* recordings from barrel cortex revealed that *Fmr1* KO mice show an enlargement in the cortical area activated by whisker deflections, that is, an expansion of the somatosensory maps in L2/3. Furthermore, the encoding of tactile stimuli at different frequencies was severely impaired in Layer 2/3 as well ([@bibr121-1759091418801092]). These findings highlight neuronal mechanisms that could contribute to the different exploratory behavior such as *tactile defensiveness* or *tactile sensitivity* ([@bibr164-1759091418801092]; [@bibr15-1759091418801092]; [@bibr140-1759091418801092]; [@bibr16-1759091418801092]), which is observed in *Fmr1* KO mice ([@bibr7-1759091418801092]; [@bibr177-1759091418801092]). Furthermore, a decrease in the whisker selectivity index is evident in *Fmr1* KO mice over a range of stimulation parameters, indicating that the specificity with which deflection of a given whisker activates cortex has decreased ([@bibr121-1759091418801092]).

Moreover, there are profound alterations in the neuronal excitability in Layer 4 of somatosensory barrel cortex in the *Fmr1* KO mouse at the synaptic, cellular, and network levels. Gibson et al.'s work on *Fmr1* KO mice somatosensory cortex has shown that there is a decrease in connectivity frequency and strength resulting in an approximate 50% reduction in excitatory drive onto fast-spiking (FS) inhibitory interneurons. In addition, excitatory neurons become intrinsically more excitable in the KO mice. These changes can lead to hyperexcitable circuits, a hypothesis that was supported by observed increase in UP state duration in somatosensory cortex of *Fmr1* KO mice ([@bibr91-1759091418801092]). Consistent with impaired FS inhibitory circuitry, network synchrony within a single cortical column during the UP state is decreased as well ([@bibr91-1759091418801092]). Similar to our findings in the auditory cortex ([@bibr216-1759091418801092]), there is a significant reduction in PV immunoreactivity in the somatosensory cortex of adult *Fmr1* KO mice ([@bibr183-1759091418801092]). PV interneurons receive both intracortical and thalamic excitatory inputs, which develop during the cortical critical period ([@bibr48-1759091418801092]; [@bibr35-1759091418801092]). A recent study has shown that there is a significant delay in the formation of excitatory contacts onto FS interneurons, which likely has a large impact on the integration of feedforward inhibitory circuits in the developing somatosensory cortex of *Fmr1* KO mice ([@bibr152-1759091418801092]).

Gonçalves et al. showed that *Fmr1* KO mice exhibit abnormally high synchrony of neocortical network activity in mouse somatosensory cortex, especially during development. Neuronal firing rates are significantly higher in *Fmr1* KO mice compared with WT mice during whole-cell recordings manifesting UP/Down states (slow-wave sleep, quiet wakefulness), probably due to the higher firing probability during UP states. Combined electroencephalography and calcium imaging experiments confirmed that neurons in KO mice have abnormally high firing and synchrony during sleep, leading to the conclusion that cortical networks in FXS are hyperexcitable in a brain state-dependent manner during a critical period for experience-dependent plasticity ([@bibr93-1759091418801092]). Several studies have also shown both molecular and functional disruption in GABA signaling in FXS ([@bibr69-1759091418801092]; [@bibr54-1759091418801092]; [@bibr89-1759091418801092]; [@bibr157-1759091418801092]). The timing of the switch from depolarizing to hyperpolarizing GABA is delayed in the somatosensory cortex of *Fmr1* KO mice, and there is a concurrent alteration in the expression of the neuronal chloride cotransporter NKCC1 that promotes the accumulation of intracellular chloride ([@bibr102-1759091418801092]). While the actual mechanisms that control the developmental expression of the NKCC1 are not known, it is significant that NKCC1 is predominantly found in astrocytes. With the discovery of FMRP in astrocytes ([@bibr155-1759091418801092]), coupled with a role of astrocytes in synaptic function and glutamate metabolism ([@bibr204-1759091418801092]; [@bibr72-1759091418801092]; [@bibr156-1759091418801092]), it is possible that astrocytes contribute, in some capacity, to the abnormal dendritic spine and synapse development, as well as circuit hyperexcitability seen in FXS ([@bibr117-1759091418801092]; [@bibr118-1759091418801092]; [@bibr105-1759091418801092]; [@bibr106-1759091418801092]). Abnormal trophic effects of GABA during cortical development may also disrupt the normal trophic function of GABA and contribute to the delayed maturation of glutamatergic synapses in FXS.

Cellular deficits have also been observed in the somatosensory cortex of *Fmr1* KO mice. As in the auditory and visual cortices, an abundance of abnormally long, thin dendritic spines have been reported in pyramidal neurons during early development in the somatosensory cortex ([@bibr151-1759091418801092]; [@bibr88-1759091418801092]), and abnormal developmental pruning of the Layer 4 spiny stellate cell dendrites has been described in *Fmr1* KO mice ([@bibr87-1759091418801092]). Despite the clear alterations in cellular morphology in *Fmr1* KO mice, it is not known whether the anatomical deficits have an impact on the functional development of excitatory glutamatergic synapses in somatosensory cortex. During perinatal development in rodents, activity-dependent refinement of excitatory thalamocortical synapses in the somatosensory cortex leads to a stereotypical maturation of glutamatergic signaling ([@bibr39-1759091418801092]; [@bibr18-1759091418801092]). Thalamocortical synapses exhibit LTP and LTD throughout the critical plasticity period in Layer 4 ([@bibr39-1759091418801092]; [@bibr78-1759091418801092]). Activity-dependent maturation of excitatory thalamocortical synapses during the critical period results in rapid changes in the synaptic composition of glutamate receptors ([@bibr39-1759091418801092]; [@bibr123-1759091418801092]; [@bibr49-1759091418801092]). The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor contribution increases relative to the *N*-methyl-*D*-aspartate (NMDA) receptors ([@bibr39-1759091418801092]), and the proportion of NMDA-only silent synapses is reduced ([@bibr115-1759091418801092]).

Cortical glutamate receptors have been implicated in the development of the barrel cortex maps and the refinement of cortical sensory circuits that underlie sensory processing ([@bibr180-1759091418801092]). [@bibr99-1759091418801092] showed that early postnatal development of excitatory connections from the thalamus to Layer 4 spiny stellate neurons is critically disrupted during a critical plasticity period in *Fmr1* KO mice. Moreover, the progressive development of excitatory ionotropic glutamate receptor signaling, which normally occurs over the first postnatal week, is delayed as well ([@bibr99-1759091418801092]; [@bibr202-1759091418801092]). There is also an altered NMDAR-to-AMPAR ratio observed in the somatosensory cortex of *Fmr1* KO mice manifesting as an increase in the fraction of silent synapses (NMDA-only thalamocortical synapses) at the closure of the critical plasticity period ([@bibr99-1759091418801092]). Synaptic plasticity and experience-dependent refinement of sensory circuits are inextricably linked, and NMDA receptors play a central role in both processes. Therefore, alteration in NMDA receptor signaling and the developmental maturation of silent synapses during the critical plasticity period will most likely affect the development of cortical circuits.

Just like in the auditory and visual cortices, FMRP is required for the normal developmental progression of synaptic maturation in the somatosensory cortex. Loss of FMRP impacts the development of cortical synapses and results in dysregulation of glutamatergic maturation in the somatosensory cortex during the early postnatal critical plasticity period. Moreover, increased proportion of silent synapses persists into late postnatal development, which coincides with a temporal delay in the window for synaptic plasticity ([@bibr99-1759091418801092]; [@bibr202-1759091418801092]).

Conclusions and Future Studies {#sec6-1759091418801092}
==============================

Hyperarousal and anxiety in humans with FXS may be linked to strong reactions to sensory stimuli. There is an abundance of evidence describing sensory cortical dysfunctions in the *Fmr1* KO mice and in humans with FXS ([Table 1](#table1-1759091418801092){ref-type="table"}). The common underlying phenotype is *sensory hypersensitivity*, including hypersensitivity to visual, auditory, or tactile stimuli that may lead to behavioral alterations such as poor eye contact, avoidance of noisy places, anxiety, and impaired social reciprocity. These alterations in sensory processing appear to be a universal problem in individuals with FXS, as they cause impairment in processing and encoding of many types of sensory information, which may affect more complex social behaviors. Moreover, sensory processing disorders could occur because of dysfunction at multiple levels of each sensory system. The *Fmr1* KO mice also display deficiencies in sensory processing that may help to understand the mechanism of sensory hypersensitivity in FXS ([Figure 2](#fig2-1759091418801092){ref-type="fig"}). Mechanisms underlying the sensory hypersensitivity may be relatively more tractable compared with more complex social behaviors typically studied in FXS. Therefore, it is of critical importance to use sensory hypersensitivity as a robust, reliable, and translatable phenotype to integrate preclinical and clinical investigations at multiple levels of analysis to facilitate drug discovery in FXS.

###### 

Impaired Sensory Mechanisms in Fragile X Syndrome.

![](10.1177_1759091418801092-table1)

  Mechanisms                                                                                                                                                                                                                                     Auditory   Somatosensory   Visual                                                        Other systems
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- --------------- ------------------------------------------------------------- -------------------------------------------------------------
  Immature dendritic spine morphology ([@bibr37-1759091418801092]; [@bibr114-1759091418801092]; [@bibr151-1759091418801092]; [@bibr127-1759091418801092]; [@bibr88-1759091418801092]; [@bibr22-1759091418801092]; [@bibr201-1759091418801092])   m          m               h^[](#table-fn2-1759091418801092){ref-type="table-fn"}a^, m   h^[](#table-fn2-1759091418801092){ref-type="table-fn"}a^, r
  Altered critical period plasticity ([@bibr60-1759091418801092]; [@bibr93-1759091418801092]; [@bibr124-1759091418801092])                                                                                                                       m          m               m                                                             
  Enhanced mGluR5 signaling ([@bibr20-1759091418801092]; [@bibr60-1759091418801092]; [@bibr59-1759091418801092]; [@bibr101-1759091418801092]; [@bibr124-1759091418801092])                                                                       m          m               m                                                             m
  Abnormal E/I balance in cortical circuits ([@bibr161-1759091418801092]; [@bibr91-1759091418801092]; [@bibr26-1759091418801092]; [@bibr23-1759091418801092])                                                                                    m          m               r                                                             
  Abnormal PV cell development ([@bibr183-1759091418801092]; [@bibr152-1759091418801092]; [@bibr216-1759091418801092])                                                                                                                           m          m                                                                             
  Enlarged receptive fields and prolong responses ([@bibr171-1759091418801092]; [@bibr121-1759091418801092])                                                                                                                                     m          m                                                                             
  Enhanced long-term depression and deficient cortical long-term potentiation ([@bibr134-1759091418801092]; [@bibr230-1759091418801092]; [@bibr217-1759091418801092]; [@bibr148-1759091418801092]; [@bibr116-1759091418801092])                             m               m                                                             r, z
  Enhanced MMP-9 activity ([@bibr24-1759091418801092]; [@bibr92-1759091418801092]; [@bibr187-1759091418801092])                                                                                                                                  m                                                                                        h^[](#table-fn2-1759091418801092){ref-type="table-fn"}a^
  Delayed extracellular matrix and perineuronal net development ([@bibr98-1759091418801092]; [@bibr216-1759091418801092])                                                                                                                        m                                                                                        
  Abnormally high amplitude of the N1 wave and reduced habituation ([@bibr32-1759091418801092]; [@bibr182-1759091418801092]; [@bibr73-1759091418801092])                                                                                         h, m                                                                                     
  Enhanced resting gamma and reduced phase-locking response ([@bibr74-1759091418801092]; [@bibr214-1759091418801092])                                                                                                                            h                                                                                        
  Impaired cortical representation of speech sounds ([@bibr70-1759091418801092])                                                                                                                                                                 r                                                                                        
  Disruption of thalamocortical synapse during critical period plasticity ([@bibr49-1759091418801092]; [@bibr99-1759091418801092])                                                                                                                          m                                                                             
  Delayed depolarizing to hyperpolarizing GABA switch ([@bibr102-1759091418801092])                                                                                                                                                                         m                                                                             
  Altered NMDAR to AMPAR ratio ([@bibr99-1759091418801092])                                                                                                                                                                                                 m                                                                             
  Abnormal magnocellular pathway ([@bibr127-1759091418801092])                                                                                                                                                                                                              h                                                             
  Disruption of the dorsal stream ([@bibr126-1759091418801092]; [@bibr75-1759091418801092])                                                                                                                                                                                 h                                                             
  Altered retinal function and synaptic structure ([@bibr170-1759091418801092])                                                                                                                                                                                             m                                                             
  Defects in synaptic transmission in the optic lobe ([@bibr228-1759091418801092])                                                                                                                                                                                          d                                                             
  Impaired long-term olfactory habituation ([@bibr196-1759091418801092])                                                                                                                                                                                                                                                                  d
  Reduced specificity in odor coding and alterations ([@bibr83-1759091418801092])                                                                                                                                                                                                                                                         d
  Defects at neuromuscular junctions and mushroom bodies ([@bibr139-1759091418801092]; [@bibr224-1759091418801092]; [@bibr160-1759091418801092]; [@bibr228-1759091418801092])                                                                                                                                                             d
  Altered circadian rhythm behaviors ([@bibr58-1759091418801092]; [@bibr113-1759091418801092]; [@bibr142-1759091418801092]; [@bibr225-1759091418801092])                                                                                                                                                                                  m, d

*Note*. PV = parvalbumin; MMP-9 = matrix metalloproteinase-9; GABA = gamma-aminobutyric acid; NMDAR = *N*-methyl-*D*-aspartate receptor; AMPAR = α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; h = human; m = mouse; r = rat; d = *Drosophila*; z = zebrafish.

^a^Postmortem tissue.

![Auditory, visual, and somatosensory processing phenotypes observed in FXS.\
MMP-9 = matrix metalloproteinase-9; LTD = long-term depression; LTP = long-term potentiation; CPP = critical period plasticity; mGluR5 = metabotropic glutamate receptor 5; E/I = excitatory/inhibitory; PV = parvalbumin interneurons; GABA = gamma-aminobutyric acid; NMDAR = *N*-methyl-*D*-aspartate receptor; AMPAR = α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor.](10.1177_1759091418801092-fig2){#fig2-1759091418801092}

Indeed, studies of mouse sensory hypersensitivity neurobehavioral phenotypes have led to a better understanding of circuit-level pathophysiology in FXS. The heightened sensory activity seen in humans with FXS may stem from a concurrence of dysfunctional intrinsic excitability or impaired inhibition due to a loss or abnormal development of inhibitory neurons, abnormal dendrite morphology, or reduced GABAergic activity. The molecular and cellular mechanisms of circuit hyperexcitability are beginning to be understood. *Fmr1* KO mouse somatosensory and auditory cortex show weakened inhibitory interneuron activity and more excitable pyramidal neurons that may underlie changes in sensory and high-order cognitive behaviors seen in *Fmr1* KO mice ([Figure 2](#fig2-1759091418801092){ref-type="fig"}). Disrupted cytoarchitecture of sensory circuits in *Fmr1* KO mice during early development may impair the ability of mice to integrate sensory experiences leading to abnormal sensory circuit development, learning, and high-order cognitive skills that persist into adulthood.

FXS is a neurodevelopmental disorder, but the mechanisms of impaired development of functional neural response selectivity to sensory stimuli are still unclear. The predominant focus of published work in the FXS field has been on characterizing the changes in dendritic spine properties and synaptic or intrinsic properties of neurons. However, the consequences of these synaptic changes to development of behaviorally relevant neural response properties in FXS are not known. Therefore, it is not clear if the observed sensory hypersensitivity in humans with FXS is due to an altered regulation of developmental processes during critical plasticity period that persists into adulthood. The majority of studies using *Fmr1* KO mice focus on the neuronal responses and behaviors during a specific developmental window or in adult mice while neglecting to look at any long-term changes in *Fmr1* KO mice from early development into adulthood and the long-term impact of early treatment to reverse FXS-associated behavioral deficits. Is the loss of FMRP only detrimental during a critical plasticity period or are the changes attributed to the ongoing absence of FMRP? A recent finding that eliminating FMRP in only the prefrontal cortex of adult mice can lead to abnormal learning suggests FMRP continues to plays a role in neural function even after critical plasticity period ends ([@bibr188-1759091418801092]). In addition, some phenotypes are reversed in the adult animal models by acute pharmacological treatments. However, it is not clear whether the acute effects are long-lasting. Moreover, chronic treatments may result in drug tolerance. Further studies are needed to determine developmental versus adult effects of FMRP loss on cortical responses to identify specific time windows, which can be targeted therapeutically.

Questions on whether the animal models are appropriate to study human neurological disorders have arisen due to the inability to translate preclinical therapeutic success to the clinic ([@bibr43-1759091418801092]). Indeed it is important to compare multiple model systems for any neurological disorder. Regardless of the animal model studied (even in nonhuman primates), the manifestation of cognitive and social symptoms will depend on underlying circuits that are quite different across species. The development of these circuits is also difficult to probe. Sensory processing circuits and mechanisms are more likely to show relatively more similarities. This is seen in FXS studies that show very similar baseline and sound-evoked EEG phenotypes in mice and humans ([@bibr182-1759091418801092]; [@bibr137-1759091418801092]; [@bibr74-1759091418801092]; [@bibr192-1759091418801092]; [@bibr214-1759091418801092]). In addition, few studies of FXS (in humans and mice) have quantified developmental trajectories and roles of FMRP ([Table 1](#table1-1759091418801092){ref-type="table"}). Again, when additional model systems are studied, it is imperative to analyze changes in circuit function over development. Therefore, we argue that development of sensory hypersensitivity may be used as a neurobehavioral probe to more successfully evaluate and translate drug treatments from preclinical models to humans, as well as underlying mechanisms of FXS-associated deficits.
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